Background and Principle

Exosomes are small extracellular vesicles (EVs) ranging from approximately 30 to 150 nm in diameter that are secreted by nearly all cell types into the extracellular space. They carry a cargo of proteins, lipids, mRNAs, microRNAs, and other non-coding RNAs that reflect the physiological or pathological state of the parent cell, making them attractive targets for biomarker discovery, liquid biopsy, and cell-communication research.

Traditional exosome isolation by differential ultracentrifugation is time-consuming, requires specialized equipment, and yields variable results between laboratories. The Exosome Isolation Kit (E771324) employs a polymer-based precipitation strategy that reduces hydration shells around vesicles, causing them to precipitate at low centrifugation speeds (as low as 1,500 × g). The resulting pellet is resuspended in a buffer compatible with a wide range of downstream analytical techniques.

Because cell culture conditioned media and urine differ substantially in protein content, volume, and osmolality, separate optimized protocols are recommended for each matrix to ensure maximum recovery and purity.

Sample Preparation

Cell Culture Conditioned Media:

• Grow cells under standard conditions. For exosome studies, deplete exosomes from serum supplements by ultracentrifugation (100,000 × g, ≥18 h at 4 °C) or use commercially available exosome-depleted FBS prior to cell culture.
• Collect conditioned media after the desired culture period (typically 24–72 h).
• Centrifuge at 300 × g for 10 min at 4 °C to remove cells, then at 2,000 × g for 20 min to remove dead cells and large debris, and finally at 10,000 × g for 30 min to remove large vesicles and apoptotic bodies. Transfer the clarified supernatant for kit use.
• Process samples immediately or store at −80 °C in aliquots to avoid repeated freeze–thaw cycles.

Urine:

• Collect mid-stream urine under sterile conditions into a clean container. Process within 4 h of collection or store at −80 °C.
• Centrifuge at 2,000 × g for 10 min at 4 °C to remove cells and debris, then at 10,000 × g for 30 min to pellet larger particles. Collect the clarified supernatant.
• Urine samples may require pH adjustment to 7.0–7.4 and may benefit from a protease inhibitor cocktail to protect exosomal protein cargo.

Isolation Protocol (Step-by-Step Workflow)

The following workflow applies to both cell culture conditioned media and urine samples after pre-clearing steps described in Sample Preparation.

1. Volume Measurement: Measure the volume of clarified sample. Adjust to the volume range recommended in the kit insert.
2. Reagent Addition: Add the Exosome Isolation Reagent at the ratio specified in the product datasheet (typically 0.2 volumes of reagent per 1 volume of sample). Mix thoroughly by vortexing or inversion until homogeneous.
3. Incubation: Incubate the mixture at 4 °C for the time specified in the product insert (commonly overnight or as directed). Consistent incubation times improve reproducibility.
4. Centrifugation: Centrifuge the incubated mixture at 1,500 × g for 30 min at 4 °C. Carefully aspirate and discard the supernatant without disturbing the pellet.
5. Resuspension: Resuspend the pellet in an appropriate volume of sterile 1× PBS or the resuspension buffer provided, depending on the intended downstream application. Pipette gently to achieve a homogeneous suspension.
6. Storage or Downstream Use: Use isolated exosomes immediately for functional studies or store at −80 °C in aliquots. Avoid repeated freeze–thaw cycles, which can impair vesicle integrity.

Note: Always refer to the current version of the product insert supplied with each lot for exact volumes, ratios, and centrifugation parameters, as these may be refined between lots.

Downstream Characterization and Quality Control

Verification of exosome identity and quality is essential before proceeding to functional or biomarker studies. Recommended characterization approaches include:

• Nanoparticle Tracking Analysis (NTA): Determines particle size distribution and concentration. Exosomes should appear predominantly in the 30–150 nm range.
• Transmission Electron Microscopy (TEM): Confirms the cup-shaped morphology characteristic of exosomes fixed under standard EM conditions.
• Western Blotting for Canonical Markers: Detect tetraspanins (CD9, CD63, CD81) and heat shock proteins (HSP70, HSP90) as positive markers. Absence of endoplasmic reticulum marker calnexin confirms that the preparation is not heavily contaminated with cellular organelles.
• Protein Quantification: Use a BCA or Bradford assay to determine total protein concentration of the preparation, enabling normalization across experiments.
• RNA Profiling: If nucleic acid cargo is of interest, extract RNA using an exosome-compatible RNA isolation kit and assess quality by Bioanalyzer or Qubit before sequencing or RT-qPCR.

Establishing quality control benchmarks within your laboratory (e.g., particle-to-protein ratio, marker positivity) ensures consistency between experiments and operators.

Troubleshooting and Best Practices

Consult the table below for common issues and recommended corrective actions:

• Low Yield: Ensure that pre-clearing centrifugation steps are not overly aggressive (avoid >10,000 × g before the kit step). Confirm that the reagent-to-sample ratio and incubation time are followed precisely. For urine, ensure pH is within the recommended range.
• High Background / Protein Contamination: Verify that exosome-depleted serum was used during cell culture. For urine samples, dilution of the sample prior to processing can reduce abundant urinary proteins such as Tamm-Horsfall protein (uromodulin).
• Poor Pellet Formation: Check that the incubation was performed at 4 °C and not at room temperature. Ensure the sample was not frozen during incubation. Mix the sample and reagent more thoroughly before incubation.
• Inconsistent Results Between Runs: Standardize cell passage number, cell density at collection, and media volume. For urine, standardize collection time-of-day and hydration status of donors where possible, and normalize results to urinary creatinine.
• Aggregates in Resuspended Pellet: Resuspend gently with a wide-bore pipette tip. If aggregates persist, pass the suspension through a 0.45 µm syringe filter (note: this may reduce total particle count).

General Best Practices: Keep all samples and reagents on ice during processing. Use low-binding microcentrifuge tubes to minimize vesicle adhesion to tube walls. Label all tubes with lot number, date, and sample identity to ensure traceability.